Enlaza Therapeutics Appoints Jeffrey Leiden, M.D., Ph.D., As Key Advisor
18 Jun 2024 //
BUSINESSWIRE
Enlaza Therapeutics secures $100m in Series A funding
01 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Enlaza Raises $100M Series A Led By J.P. Morgan Private Capital
30 Apr 2024 //
BUSINESSWIRE
Enlaza gets JP Morgan, Regeneron backing for covalent biologics
30 Apr 2024 //
BIOPHARMADIVE